4.7 Letter

Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 148, Issue 1, Pages 96-98

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2021.03.034

Keywords

-

Funding

  1. Swedish Research Council [201802752]
  2. Swedish government [76800, 76210]
  3. Swedish county councils, the ALF-agreement [76800, 76210]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available